FOX CHASE CANCER CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
- Conditions
- Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA)
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT06984562
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
- Conditions
- CIPN - Chemotherapy-Induced Peripheral NeuropathyPain
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT06914557
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Communication About Sexual Health in Gynecologic Cancer
- Conditions
- Gynecologic Cancers
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT06904339
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
- Conditions
- Neoplasm
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 186
- Registration Number
- NCT06782581
- Locations
- 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.
- Conditions
- Care DeliveryGeriatricsGeriatric Assessment
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06652347
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
- Conditions
- Indolent Non-hodgkin LymphomaLymphoma
- Interventions
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT06557330
Testing Gene PilotLX with Latinx Cancer Patients
- Conditions
- Cancer
- Interventions
- Other: Gene PilotLX
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 232
- Registration Number
- NCT06476938
- Locations
- 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States
🇺🇸Herbert Irving Comprehensive Cancer Center, New York, New York, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
HPV Self-sampling for Underscreened Latinas
- Conditions
- Uterine Cervical Neoplasm
- Interventions
- Behavioral: HPV Self-SamplingBehavioral: Group Education
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 108
- Registration Number
- NCT06439706
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Genomic Risk in Retroperitoneal Sarcoma
- Conditions
- Soft Tissue SarcomaRetroperitoneal Liposarcoma
- Interventions
- Other: Biospecimen sample collection during standard-of-care surgery
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT06436846
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Reducing Urban Cervical Cancer Disparities
- Conditions
- Cervical CancerPapilloma Viral Infection
- Interventions
- Behavioral: Stage 1 SOCBehavioral: Stage 1 HERSBehavioral: Stage 3 HERSBehavioral: Stage 2 HERSBehavioral: Stage 3 SOCBehavioral: Stage 2 HERS+HCBehavioral: Stage 4 HERSBehavioral: Stage 4 HERS+HCBehavioral: Stage 3 HERS+HC
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 546
- Registration Number
- NCT06416150
- Locations
- 🇺🇸
Rutgers, The State University of New Jersey, New Brunswick, New Jersey, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States